Cheri Ackerman

Company: Concerto Biosciences

Job title: Co-Founder & Chief Executive Officer

Seminars:

From AI-Based Discovery to the Clinic: Using Millions of Measurements to Speed Discovery, with ENS-002 for Atopic Dermatitis as a Clinical-Stage Example 3:00 pm

Employ AI to analyse large-scale microbial interaction data and predict the performance of novel microbial combinations and by-products, prioritising those with the highest activity Discovery and development of ENS-002, a live biotherapeutic product providing ultrasafe, long-term relief from atopic dermatitis, now in Phase 1b trialsRead more

day: Day Two